These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
265 related items for PubMed ID: 21072520
1. Antitumor effects of (S)-HDAC42, a phenylbutyrate-derived histone deacetylase inhibitor, in multiple myeloma cells. Bai LY, Omar HA, Chiu CF, Chi ZP, Hu JL, Weng JR. Cancer Chemother Pharmacol; 2011 Aug; 68(2):489-96. PubMed ID: 21072520 [Abstract] [Full Text] [Related]
8. Histone deacetylase inhibitors synergistically potentiate death receptor 4-mediated apoptotic cell death of human T-cell acute lymphoblastic leukemia cells. Sung ES, Kim A, Park JS, Chung J, Kwon MH, Kim YS. Apoptosis; 2010 Oct; 15(10):1256-69. PubMed ID: 20582477 [Abstract] [Full Text] [Related]
9. Antitumor effects of a novel phenylbutyrate-based histone deacetylase inhibitor, (S)-HDAC-42, in prostate cancer. Kulp SK, Chen CS, Wang DS, Chen CY, Chen CS. Clin Cancer Res; 2006 Sep 01; 12(17):5199-206. PubMed ID: 16951239 [Abstract] [Full Text] [Related]
10. Triptolide overcomes dexamethasone resistance and enhanced PS-341-induced apoptosis via PI3k/Akt/NF-kappaB pathways in human multiple myeloma cells. Yang M, Huang J, Pan HZ, Jin J. Int J Mol Med; 2008 Oct 01; 22(4):489-96. PubMed ID: 18813856 [Abstract] [Full Text] [Related]
11. The histone deacetylase inhibitor suberoylanilide hydroxamic acid induces growth inhibition and enhances taxol-induced cell death in breast cancer. Shi YK, Li ZH, Han XQ, Yi JH, Wang ZH, Hou JL, Feng CR, Fang QH, Wang HH, Zhang PF, Wang FS, Shen J, Wang P. Cancer Chemother Pharmacol; 2010 Nov 01; 66(6):1131-40. PubMed ID: 20838997 [Abstract] [Full Text] [Related]
12. Combined treatment with Ad-hTRAIL and DTIC or SAHA is associated with increased mitochondrial-mediated apoptosis in human melanoma cell lines. Lillehammer T, Engesaeter BO, Prasmickaite L, Maelandsmo GM, Fodstad O, Engebraaten O. J Gene Med; 2007 Jun 01; 9(6):440-51. PubMed ID: 17410615 [Abstract] [Full Text] [Related]
13. Enhancement of cisplatin cytotoxicity by SAHA involves endoplasmic reticulum stress-mediated apoptosis in oral squamous cell carcinoma cells. Suzuki M, Endo M, Shinohara F, Echigo S, Rikiishi H. Cancer Chemother Pharmacol; 2009 Nov 01; 64(6):1115-22. PubMed ID: 19280190 [Abstract] [Full Text] [Related]
14. Brazilin induces apoptosis and G2/M arrest via inactivation of histone deacetylase in multiple myeloma U266 cells. Kim B, Kim SH, Jeong SJ, Sohn EJ, Jung JH, Lee MH, Kim SH. J Agric Food Chem; 2012 Oct 03; 60(39):9882-9. PubMed ID: 22967175 [Abstract] [Full Text] [Related]
15. Modulation of radiation response by histone deacetylase inhibition. Chinnaiyan P, Vallabhaneni G, Armstrong E, Huang SM, Harari PM. Int J Radiat Oncol Biol Phys; 2005 May 01; 62(1):223-9. PubMed ID: 15850925 [Abstract] [Full Text] [Related]
16. Synergistic interaction of the histone deacetylase inhibitor SAHA with the proteasome inhibitor bortezomib in mantle cell lymphoma. Heider U, von Metzler I, Kaiser M, Rosche M, Sterz J, Rötzer S, Rademacher J, Jakob C, Fleissner C, Kuckelkorn U, Kloetzel PM, Sezer O. Eur J Haematol; 2008 Feb 01; 80(2):133-42. PubMed ID: 18005386 [Abstract] [Full Text] [Related]
19. Histone deacetylase inhibitors induce growth arrest and apoptosis of HTLV-1-infected T-cells via blockade of signaling by nuclear factor kappaB. Nishioka C, Ikezoe T, Yang J, Komatsu N, Bandobashi K, Taniguchi A, Kuwayama Y, Togitani K, Koeffler HP, Taguchi H. Leuk Res; 2008 Feb 01; 32(2):287-96. PubMed ID: 17644177 [Abstract] [Full Text] [Related]